Core Viewpoint - The article discusses various tax incentives and policies aimed at supporting high-tech enterprises, small and micro enterprises, and specific sectors such as pharmaceuticals and technology transfer, highlighting the benefits of these policies for businesses in terms of tax reductions and deductions [4][12][11]. Group 1: High-Tech Enterprise Incentives - High-tech enterprises are subject to a reduced corporate income tax rate of 15% [4]. - Losses incurred in the five years prior to qualifying as a high-tech enterprise can be carried forward for up to 10 years for tax offset [4]. Group 2: Equipment and Depreciation Policies - From January 1, 2024, to December 31, 2027, enterprises can deduct the full cost of newly purchased equipment valued under 5 million yuan in the year of purchase, rather than depreciating it over several years [5]. - The definition of equipment includes fixed assets excluding buildings, and the timing of asset recognition is based on invoice issuance or completion of construction [17]. Group 3: Pharmaceutical Sector Benefits - Pharmaceutical manufacturing companies can deduct advertising and promotional expenses up to 30% of their annual sales revenue, with excess amounts allowed to be carried forward to future tax years [9]. - Income from the initial processing of medicinal plants is exempt from corporate income tax [9]. Group 4: Technology Transfer Tax Relief - For technology transfer income, the first 5 million yuan is exempt from corporate income tax, while amounts exceeding this threshold are taxed at half the standard rate [11]. Group 5: Small and Micro Enterprise Policies - Small and micro enterprises can calculate taxable income at a reduced rate of 25% and pay corporate income tax at a rate of 20%, with this policy extended until December 31, 2027 [12]. - Criteria for small and micro enterprises include annual taxable income not exceeding 3 million yuan, fewer than 300 employees, and total assets not exceeding 50 million yuan [12].